The rationale for quadrivalent influenza vaccines

por Ambrose, Christopher S., Levin, Myron J.
Publicado 2012

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

por Ambrose, Christopher S., Levin, Myron J., Belshe, Robert B.
Publicado 2010

Safety and Varicella Outcomes in In Utero–Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Pr...

por Duchon, Jennifer M, Levin, Myron J, Gershon, Anne A
Publicado 2019

Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes...

por Levin, Myron J., Duchon, Jennifer M., Swamy, Geeta K., Gershon, Anne A.
Publicado 2019

Incidence of Herpes Zoster and Persistent Post-Zoster Pain in Adults With or Without Diabetes in the United States

por Suaya, Jose A., Chen, Shih-Yin, Li, Qian, Burstin, Stuart J., Levin, Myron J.
Publicado 2014

Cost of Herpes Zoster in Patients With Selected Immune-Compromised Conditions in the United States

por Li, Qian, Chen, Shih-Yin, Burstin, Stuart J., Levin, Myron J., Suaya, Jose A.
Publicado 2016

An outbreak of rotavirus-associated neonatal necrotizing enterocolitis()

por Rotbart, Harley A., Levin, Myron J., Yolken, Robert H., Manchester, David K., Jantzen, James
Publicado 1983

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis...

por Dagnew, Alemnew F, Rausch, Debora, Hervé, Caroline, Zahaf, Toufik, Levin, Myron J, Schuind, Anne
Publicado 2020

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines

por Park, Seong Yeon, Levin, Myron J., Canniff, Jennifer, Johnson, Michael, Schmid, D. Scott, Weinberg, Adriana
Publicado 2022

Recruitment of naive CD4(+) T cells by the recombinant zoster vaccine correlates with persistent immunity

por Laing, Kerry J., Ford, Emily S., Johnson, Michael J., Levin, Myron J., Koelle, David M., Weinberg, Adriana
Publicado 2023

Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influ...

por Levin, Myron J., Divino, Victoria, Shah, Drishti, DeKoven, Mitch, Mould-Quevedo, Joaquin, Pelton, Stephen I., Postma, Maarten J.
Publicado 2021

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Se...

por levin, myron J, Divino, Victoria, Pelton, Stephen I, Postma, Maarten, Shah, Drishti, Mould-Quevedo, Joaquin F, DeKoven, Mitchell
Publicado 2021

1354. Safety of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of COVID-19: 15-Month Final Analysis of the PROVENT Phase 3 Study

por Levin, Myron J, Ustianowski, Andrew, De Wit, Stéphane, Beavon, Rohini, Thissen, Jesse, Seegobin, Seth, Streicher, Katie, Kiazand, Alexandre, Esser, Mark T
Publicado 2023

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

por Falloon, Judith, Yu, Jing, Esser, Mark T, Villafana, Tonya, Yu, Li, Dubovsky, Filip, Takas, Therese, Levin, Myron J, Falsey, Ann R
Publicado 2017

A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019–2020 Inf...

por Divino, Victoria, Ruthwik Anupindi, Vamshi, DeKoven, Mitch, Mould-Quevedo, Joaquin, Pelton, Stephen I, Postma, Maarten J, Levin, Myron J
Publicado 2021

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine

por Callegaro, Andrea, Burny, Wivine, Hervé, Caroline, Hyung Kim, Joon, Levin, Myron J, Zahaf, Toufik, Cunningham, Anthony L, Didierlaurent, Arnaud M
Publicado 2021

Vaccination against herpes zoster in developed countries: State of the evidence

por Drolet, Mélanie, Oxman, Michael N., Levin, Myron J., Schmader, Kenneth E., Johnson, Robert W., Patrick, David, Mansi, James A., Brisson, Marc
Publicado 2013

26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis

por Callegaro, Andrea, Willer, David O, Burny, Wivine, Hervé, Caroline, Kim, Joon Hyung, levin, myron J, Zahaf, Toufik, Cunningham, Anthony L, Didierlaurent, Arnaud
Publicado 2021

Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review

por Smith, Christiana, Forster, Jeri E., Levin, Myron J., Davies, Jill, Pappas, Jennifer, Kinzie, Kay, Barr, Emily, Paul, Suzanne, McFarland, Elizabeth J., Weinberg, Adriana
Publicado 2015

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

por Weinberg, Adriana, Muresan, Petronella, Richardson, Kelly, Fenton, Terence, Dominguez, Teresa, Bloom, Anthony, Watts, D. Heather, Abzug, Mark J., Nachman, Sharon A., Levin, Myron J.
Publicado 2015